These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 11573962)

  • 1. Anti-HIV agent MAP30 modulates the expression profile of viral and cellular genes for proliferation and apoptosis in AIDS-related lymphoma cells infected with Kaposi's sarcoma-associated virus.
    Sun Y; Huang PL; Li JJ; Huang YQ; Zhang L; Huang PL; Lee-Huang S
    Biochem Biophys Res Commun; 2001 Oct; 287(4):983-94. PubMed ID: 11573962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis.
    Viejo-Borbolla A; Schulz TF
    AIDS Rev; 2003; 5(4):222-9. PubMed ID: 15012001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In primary effusion lymphoma cells, MYB transcriptional repression is associated with v-FLIP expression during latent KSHV infection while both v-FLIP and v-GPCR become involved during the lytic cycle.
    Lacoste V; Nicot C; Gessain A; Valensi F; Gabarre J; Matta H; Chaudhary PM; Mahieux R
    Br J Haematol; 2007 Aug; 138(4):487-501. PubMed ID: 17659053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays.
    Jenner RG; Albà MM; Boshoff C; Kellam P
    J Virol; 2001 Jan; 75(2):891-902. PubMed ID: 11134302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of the HHV-8 vGCR cellular homolog gene in AIDS-associated and classic Kaposi's sarcoma: potential role of HIV-1 Tat.
    Yen-Moore A; Hudnall SD; Rady PL; Wagner RF; Moore TO; Memar O; Hughes TK; Tyring SK
    Virology; 2000 Feb; 267(2):247-51. PubMed ID: 10662620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effusion and solid lymphomas have distinctive gene and protein expression profiles in an animal model of primary effusion lymphoma.
    Yanagisawa Y; Sato Y; Asahi-Ozaki Y; Ito E; Honma R; Imai J; Kanno T; Kano M; Akiyama H; Sata T; Shinkai-Ouchi F; Yamakawa Y; Watanabe S; Katano H
    J Pathol; 2006 Aug; 209(4):464-73. PubMed ID: 16741895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pleiotropic effects of Kaposi's sarcoma herpesvirus.
    Schulz TF
    J Pathol; 2006 Jan; 208(2):187-98. PubMed ID: 16362980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch signal transduction induces a novel profile of Kaposi's sarcoma-associated herpesvirus gene expression.
    Chang H
    J Microbiol; 2006 Apr; 44(2):217-25. PubMed ID: 16728959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging targets and novel strategies in the treatment of AIDS-related Kaposi's sarcoma: bidirectional translational science.
    Dezube BJ; Sullivan R; Koon HB
    J Cell Physiol; 2006 Dec; 209(3):659-62. PubMed ID: 17001705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus.
    Cathomas G
    Herpes; 2003 Dec; 10(3):72-7. PubMed ID: 14759339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays.
    Dittmer DP
    Cancer Res; 2003 May; 63(9):2010-5. PubMed ID: 12727810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human herpesvirus 8 virology, epidemiology and related diseases.
    Katano H; Sata T
    Jpn J Infect Dis; 2000 Aug; 53(4):137-55. PubMed ID: 11056556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human herpesvirus 8 viral FLICE-inhibitory protein inhibits Fas-mediated apoptosis through binding and prevention of procaspase-8 maturation.
    Bélanger C; Gravel A; Tomoiu A; Janelle ME; Gosselin J; Tremblay MJ; Flamand L
    J Hum Virol; 2001; 4(2):62-73. PubMed ID: 11437316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of viral IL-6 expression in HHV-8-associated diseases.
    Cannon JS; Nicholas J; Orenstein JM; Mann RB; Murray PG; Browning PJ; DiGiuseppe JA; Cesarman E; Hayward GS; Ambinder RF
    J Infect Dis; 1999 Sep; 180(3):824-8. PubMed ID: 10438372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms governing expression of the v-FLIP gene of Kaposi's sarcoma-associated herpesvirus.
    Grundhoff A; Ganem D
    J Virol; 2001 Feb; 75(4):1857-63. PubMed ID: 11160684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lytic induction of Kaposi's sarcoma-associated herpesvirus in primary effusion lymphoma cells with natural products identified by a cell-based fluorescence moderate-throughput screening.
    Cho HJ; Yu F; Sun R; Lee D; Song MJ
    Arch Virol; 2008; 153(8):1517-25. PubMed ID: 18607675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of growth signalling and cell cycle by Kaposi's sarcoma-associated herpesvirus genes.
    Direkze S; Laman H
    Int J Exp Pathol; 2004 Dec; 85(6):305-19. PubMed ID: 15566428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of AIDS-associated Kaposi's sarcoma cells to Fas-mediated apoptosis.
    Mori S; Murakami-Mori K; Jewett A; Nakamura S; Bonavida B
    Cancer Res; 1996 Apr; 56(8):1874-9. PubMed ID: 8620507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular virology of Kaposi's sarcoma-associated herpesvirus.
    Moore PS; Chang Y
    Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):499-516. PubMed ID: 11313008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi's sarcoma-associated herpes virus and acquired immunodeficiency syndrome-related malignancy.
    Cannon M; Cesarman E
    Semin Oncol; 2000 Aug; 27(4):409-19. PubMed ID: 10950367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.